English

ENZOEYS and Japan Zeus Corporation Signed a Strategic Partnership to Expand the International Medical Aesthetics Market

2025/07/02
Contents
In February 2025, ENZOEYS and Japan Zeus Corporation signed a strategic cooperation agreement in Guangzhou, with a South Korean company participating as technical co-organizer. Senior executives from both parties attended the ceremony. This partnership marks the successful passage of the ENZOEYS brand RUIKD through Japanese stringent market certification, paving the way for in-depth collaboration in technological innovation and market expansion. Japan Zeus Corporation is recognized for its technological excellence and stringent quality standards in medical aesthetics equipment, exercising careful discretion in partner selection. Founded in 2020, ENZOEYS has concentrated on medical aesthetics device R&D and manufacturing, building a specialized team with market presence across Europe, East Asia, and beyond. ENZOEYS secured Zeus Corporation endorsement based on its strengths. ENZOEYS General Manager characterized this collaboration as authoritative recognition of the company's manufacturing capabilities. This collaboration will capitalize on complementary technological advantages, with Zeus Corporation's expertise strengthening ENZOEYS’ product competitiveness. Through Zeus Corporation's distribution network, ENZOEYS will accelerate international market penetration and brand recognition. From an industry standpoint, this partnership demonstrates that Chinese medical aesthetics device manufacturers have achieved world-class standards, setting an industry benchmark and encouraging broader participation in international markets. Moving forward, all three parties are expected to strengthen their partnership and collectively drive global medical aesthetics industry advancement.
Recommended

Intelligence Ushers in a New Era for the Beauty Industry | ENZOEYS Showcased Flagship Products at National Laser Cosmetics Academic Summit

2025/07/02
The 13th Chinese Conference of Laser Cosmetic Therapy and Facial Rejuvenation (CCLR) was held in Shanghai from April 17-20, 2025. ENZOEYS unveiled its innovative products at the event, highlighting semiconductor-based dual-effect skin rejuvenation solutions featuring three core technological breakthroughs. Its flagship products, including Mura K2 and SuperTouch S500, attracted significant attention. The solution aligns with life cosmetology and medical cosmetology evolution. Our exhibitors also discussed with experts on industry topics, proving the corporate philosophy of Technology Drives Beauty Industry Evolution.

ENZOEYS and Japan Zeus Corporation Signed a Strategic Partnership to Expand the International Medical Aesthetics Market

2025/07/02
In February 2025, ENZOEYS and Japan Zeus Corporation signed a strategic cooperation agreement in Guangzhou, with a South Korean company participating as technical co-organizer. Senior executives from both parties attended the ceremony. This partnership marks the successful passage of the ENZOEYS brand RUIKD through Japanese stringent market certification, paving the way for in-depth collaboration in technological innovation and […]

Breaking News: ENZOEYS Secured Class II Medical Device Manufacturing Certification

2025/06/02
In April 2025, ENZOEYS obtained its Class II Medical Device Manufacturing License, establishing itself as a nationally certified manufacturer of high-end medical aesthetics equipment. This stringently reviewed qualification validates the company's robust technological and quality capabilities. Founded in 1986, ENZOEYS holds over 100 patents with products exported globally. Following license approval, ENZOEYS upgraded its full product lifecycle management system. Looking ahead, ENZOEYS will launch five new products as part of its transformation strategy, setting a benchmark for industry development.
Contact Us
Your questions are welcome at any time